Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort.
Ferriero M, Mastroianni R, De Nunzio C, Cindolo L, Calabrò F, Tema G, Leonardo C, Flammia RS, Tuderti G, Anceschi U, Brassetti A, Giacinti S, Guaglianone S, Ghahhari J, Schips L, Tubaro A, Gallucci M, Simone G. Ferriero M, et al. Among authors: giacinti s. World J Urol. 2020 Jul;38(7):1757-1764. doi: 10.1007/s00345-019-02974-6. Epub 2019 Oct 12. World J Urol. 2020. PMID: 31605196
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate.
Giacinti S, Carlini P, Roberto M, Bassanelli M, Strigari L, Pavese F, Aschelter AM, Felici A, Valeriani M, Cognetti F, Marchetti P. Giacinti S, et al. Anticancer Drugs. 2017 Jan;28(1):110-115. doi: 10.1097/CAD.0000000000000434. Anticancer Drugs. 2017. PMID: 27763885
Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction.
Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Topazio L, Boccasile S, Ditonno P, Chiodini P, Schips L. Cindolo L, et al. Among authors: giacinti s. Clin Genitourin Cancer. 2017 Oct;15(5):520-525. doi: 10.1016/j.clgc.2017.04.003. Epub 2017 Apr 11. Clin Genitourin Cancer. 2017. PMID: 28478884 Clinical Trial.
Castration-resistance prostate cancer: what is in the pipeline?
DE Nunzio C, Presicce F, Giacinti S, Bassanelli M, Tubaro A. DE Nunzio C, et al. Among authors: giacinti s. Minerva Urol Nefrol. 2018 Feb;70(1):22-41. doi: 10.23736/S0393-2249.17.02976-9. Epub 2017 Jul 12. Minerva Urol Nefrol. 2018. PMID: 28707844 Free article. Review.
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study.
Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Boccasile S, Ditonno P, Chiodini P, Verze P, Mirone V, Schips L. Cindolo L, et al. Among authors: giacinti s. BMC Cancer. 2017 Nov 10;17(1):753. doi: 10.1186/s12885-017-3755-x. BMC Cancer. 2017. PMID: 29126389 Free PMC article. Clinical Trial.
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study.
Gacci M, Marchioni M, DE Francesco P, Natoli C, Calabrò F, Losanno T, Gianmartin C, Serni S, Doni L, DE Nunzio C, DE Tursi M, Valeriani M, Giacinti S, Álvarez-Maestro M, Scarcia M, Ludovico GM, Del Bene G, Simone G, Ferriero M, Tuderti G, Bove P, Laudisi A, Carrieri G, Cormio L, Verze P, LA Rocca R, Falsaperla M, Frantellizzi V, Greco F, DI Nicola M, Schips L, Cindolo L. Gacci M, et al. Among authors: giacinti s. Minerva Urol Nephrol. 2021 Aug;73(4):489-497. doi: 10.23736/S2724-6051.20.03723-6. Epub 2020 Aug 4. Minerva Urol Nephrol. 2021. PMID: 32748613 Free article.
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort.
Ferriero M, Prata F, Mastroianni R, De Nunzio C, Tema G, Tuderti G, Bove AM, Anceschi U, Brassetti A, Misuraca L, Giacinti S, Calabrò F, Guaglianone S, Tubaro A, Papalia R, Leonardo C, Gallucci M, Simone G. Ferriero M, et al. Among authors: giacinti s. Prostate Cancer Prostatic Dis. 2024 Mar;27(1):89-94. doi: 10.1038/s41391-022-00623-5. Epub 2022 Dec 2. Prostate Cancer Prostatic Dis. 2024. PMID: 36460734
Genomic and epigenomic alterations in prostate cancer.
Aschelter AM, Giacinti S, Caporello P, Marchetti P. Aschelter AM, et al. Among authors: giacinti s. Front Endocrinol (Lausanne). 2012 Nov 6;3:128. doi: 10.3389/fendo.2012.00128. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23133437 Free PMC article.
15 results